Heart Disease Trial, Recruiting (NCT05417490)

Heart Disease Trial, Recruiting NCT05417490 Sponsor: University Hospital, Montpellier Condition: Heart Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05417490 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Heart Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults (18 years or older) may be considered for this trial.
People who are currently in hospital for heart failure, or for another condition where heart failure is playing a significant or worsening role (such as a co-infection), as recognised by their treating doctor, may be considered.
People who agree to take part in the research and do not object to joining may be considered.

Who may not be able to join:

People who do not wish to participate are not eligible.
Women who are pregnant or breastfeeding are not eligible.
People who are not able to give their own informed consent, including those in protected adult status or considered vulnerable under French law (confirm with trial site), are not eligible.
People who are currently detained or held by a court or administrative order are not eligible.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: François ROUBILLE, PUPH, UH of Montpellier

Phone: 4.67.33.61.82

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05417490

Sponsor: University Hospital, Montpellier

Phase: Not Applicable

Status: Recruiting

Condition: Heart Disease

Trial contact: 4.67.33.61.82

More information: https://clinicaltrials.gov/study/NCT05417490

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults (18 years or older) may be considered for this trial.
People who are currently in hospital for heart failure, or for another condition where heart failure is playing a significant or worsening role (such as a co-infection), as recognised by their treating doctor, may be considered.
People who agree to take part in the research and do not object to joining may be considered.

Who may not be able to join:

People who do not wish to participate are not eligible.
Women who are pregnant or breastfeeding are not eligible.
People who are not able to give their own informed consent, including those in protected adult status or considered vulnerable under French law (confirm with trial site), are not eligible.
People who are currently detained or held by a court or administrative order are not eligible.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital, Montpellier

Registry

ClinicalTrials.gov

Start date

1 April 2025

Est. completion

1 April 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Percentage of patients participating in heart failure programs at 1 month; Percentage of patients participating in heart failure programs at 6 months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov